abstract |
The present invention is an inhibitor of poly (ADP-ribose) polymerase (PARP) and thus other than cancer, inflammatory disease, reperfusion injury, ischemic symptoms, stroke, renal failure, cardiovascular disease, cardiovascular disease Useful as a chemical or radiosensitizer for the treatment of vascular diseases, diabetes, neurodegenerative diseases, retroviral infections, retinal injury, skin aging, or UV-induced skin injury, and cancer treatment It relates to a compound represented by I), a pharmaceutically acceptable salt or a tautomer thereof. [Chemical 1] |